State Street’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$69.6M Buy
2,208,560
+63,210
+3% +$1.99M ﹤0.01% 1504
2025
Q1
$70.3M Sell
2,145,350
-42,855
-2% -$1.4M ﹤0.01% 1464
2024
Q4
$79.1M Buy
2,188,205
+31,779
+1% +$1.15M ﹤0.01% 1486
2024
Q3
$67.2M Sell
2,156,426
-7,415
-0.3% -$231K ﹤0.01% 1553
2024
Q2
$57.9M Buy
2,163,841
+125,195
+6% +$3.35M ﹤0.01% 1590
2024
Q1
$69.5M Sell
2,038,646
-23,680
-1% -$808K ﹤0.01% 1539
2023
Q4
$59.7M Buy
2,062,326
+145,316
+8% +$4.21M ﹤0.01% 1612
2023
Q3
$52.9M Buy
1,917,010
+47,718
+3% +$1.32M ﹤0.01% 1591
2023
Q2
$56.2M Sell
1,869,292
-69,842
-4% -$2.1M ﹤0.01% 1599
2023
Q1
$70.3M Buy
1,939,134
+53,734
+3% +$1.95M ﹤0.01% 1424
2022
Q4
$67.3M Sell
1,885,400
-37,895
-2% -$1.35M ﹤0.01% 1431
2022
Q3
$65.1M Sell
1,923,295
-54,886
-3% -$1.86M ﹤0.01% 1410
2022
Q2
$57.2M Buy
1,978,181
+134,042
+7% +$3.88M ﹤0.01% 1540
2022
Q1
$59.6M Buy
1,844,139
+61,282
+3% +$1.98M ﹤0.01% 1648
2021
Q4
$52M Sell
1,782,857
-44,984
-2% -$1.31M ﹤0.01% 1779
2021
Q3
$48.7M Buy
1,827,841
+361
+0% +$9.63K ﹤0.01% 1826
2021
Q2
$56.3M Buy
1,827,480
+49,818
+3% +$1.53M ﹤0.01% 1758
2021
Q1
$46.5M Buy
1,777,662
+1,913
+0.1% +$50.1K ﹤0.01% 1796
2020
Q4
$44.7M Buy
1,775,749
+2,613
+0.1% +$65.7K ﹤0.01% 1711
2020
Q3
$37M Sell
1,773,136
-65,737
-4% -$1.37M ﹤0.01% 1666
2020
Q2
$43.7M Sell
1,838,873
-7,564
-0.4% -$180K ﹤0.01% 1541
2020
Q1
$33.2M Buy
1,846,437
+161,712
+10% +$2.91M ﹤0.01% 1519
2019
Q4
$40M Buy
1,684,725
+103,564
+7% +$2.46M ﹤0.01% 1663
2019
Q3
$43.5M Sell
1,581,161
-145,015
-8% -$3.98M ﹤0.01% 1529
2019
Q2
$57.1M Buy
1,726,176
+29,086
+2% +$962K ﹤0.01% 1396
2019
Q1
$59.5M Sell
1,697,090
-3,403
-0.2% -$119K ﹤0.01% 1338
2018
Q4
$56.5M Sell
1,700,493
-139,527
-8% -$4.64M 0.01% 1278
2018
Q3
$92.6M Buy
1,840,020
+160,712
+10% +$8.09M 0.01% 1129
2018
Q2
$101M Buy
1,679,308
+232,799
+16% +$13.9M 0.01% 1032
2018
Q1
$66.3M Sell
1,446,509
-87,483
-6% -$4.01M 0.01% 1251
2017
Q4
$61.1M Buy
1,533,992
+123,613
+9% +$4.93M ﹤0.01% 1305
2017
Q3
$56.4M Buy
1,410,379
+12,895
+0.9% +$516K ﹤0.01% 1297
2017
Q2
$60.2M Buy
1,397,484
+42,165
+3% +$1.82M 0.01% 1245
2017
Q1
$42.4M Buy
1,355,319
+52,091
+4% +$1.63M ﹤0.01% 1421
2016
Q4
$32.9M Buy
1,303,228
+44,133
+4% +$1.11M ﹤0.01% 1534
2016
Q3
$31.1M Buy
1,259,095
+104,766
+9% +$2.59M ﹤0.01% 1482
2016
Q2
$23.5M Buy
1,154,329
+208,171
+22% +$4.24M ﹤0.01% 1640
2016
Q1
$14.4M Sell
946,158
-367,033
-28% -$5.6M ﹤0.01% 1943
2015
Q4
$17.7M Sell
1,313,191
-644,379
-33% -$8.66M ﹤0.01% 1802
2015
Q3
$27.5M Buy
1,957,570
+1,385,777
+242% +$19.4M ﹤0.01% 1529
2015
Q2
$9.71M Buy
571,793
+209,278
+58% +$3.55M ﹤0.01% 2284
2015
Q1
$4.38M Buy
362,515
+60,662
+20% +$733K ﹤0.01% 2634
2014
Q4
$2.51M Buy
301,853
+15,191
+5% +$126K ﹤0.01% 2943
2014
Q3
$2.49M Buy
286,662
+18,678
+7% +$162K ﹤0.01% 2896
2014
Q2
$2.94M Buy
267,984
+29,148
+12% +$319K ﹤0.01% 2876
2014
Q1
$2.13M Buy
238,836
+15,649
+7% +$140K ﹤0.01% 3035
2013
Q4
$1.69M Buy
223,187
+94,750
+74% +$715K ﹤0.01% 3131
2013
Q3
$939K Buy
128,437
+75,866
+144% +$555K ﹤0.01% 3258
2013
Q2
$338K Buy
+52,571
New +$338K ﹤0.01% 3282